The recombinant tuberculosis vaccine rBCG ΔureC::hly(+) induces apoptotic 
vesicles for improved priming of CD4(+) and CD8(+) T cells

Farinacci, Maura; Weber, Stephan; Kaufmann, Stefan H. E.

doi:10.1016/j.vaccine.2012.10.031

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

The recombinant tuberculosis vaccine rBCG ΔureC::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells

MPS-Authors

/persons/resource/persons81874

Farinacci, Maura
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82207

Weber, Stephan
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81969

Kaufmann, Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Farinacci, M., Weber, S., & Kaufmann, S. H. E. (2012). The recombinant tuberculosis vaccine rBCG ΔureC:hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells. Vaccine, 30(52), 7608-7614. doi:10.1016/j.vaccine.2012.10.031.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-BD8E-3

Abstract

There is no abstract available